SAB BIOTHERAPEUTICS INC (SABS): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in SABS · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
6
13F filers
Aggregate Value
$56.1M
Across holders
Last Price
$2.89
2026-10-08
Sector
Health Care
GICS
Quarterly fund activity3 increased2 reduced4 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 6.41M | $25.0M | 44.6% | 0.0% | Added | +$11.7M | Q2 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 3.76M | $14.7M | 26.2% | 0.0% | Unchanged | +$0 | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 2.75M | $10.7M | 19.1% | 0.0% | Reduced | $-1.1M | Q2 2026 |
| Woodline Partners LP CIK 0001784547 | Hedge Fund | 1.18M | $4.6M | 8.2% | 0.0% | Reduced | $-6.5M | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 215K | $837K | 1.5% | 0.0% | Added | +$130K | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 63K | $245K | 0.4% | 0.0% | Added | +$141K | Q2 2026 |
Added
Hedge Fund
$25.0M· 44.6% of total· 0.0% port· 6.41M sh· +$11.7M QoQ· Q2 2026
Unchanged
Hedge Fund
$14.7M· 26.2% of total· 0.0% port· 3.76M sh· +$0 QoQ· Q2 2026
Reduced
Hedge Fund
$10.7M· 19.1% of total· 0.0% port· 2.75M sh· $-1.1M QoQ· Q2 2026
Reduced
Hedge Fund
$4.6M· 8.2% of total· 0.0% port· 1.18M sh· $-6.5M QoQ· Q2 2026
Added
Hedge Fund
$837K· 1.5% of total· 0.0% port· 215K sh· +$130K QoQ· Q2 2026
Added
Hedge Fund
$245K· 0.4% of total· 0.0% port· 63K sh· +$141K QoQ· Q2 2026
Loading recent insider activity…